| Helga Stockton |
hst******@audentestx.com
|
Audentes Therapeutics |
Vice President, Quality |
Biotechnology |
Sharon, MA, US |
|
| Shannise Brown-Fermin |
sbr**********@audentestx.com
|
Audentes Therapeutics |
Head Global Market Access Gene Therapy |
Biotechnology |
San Francisco, CA, US |
|
| Vandana sharma |
vsh****@audentestx.com
|
Audentes Therapeutics |
Head of Direct Procurement |
Biotechnology |
New York, NY, US |
|
| Christine Leonard |
cle*****@audentestx.com
|
Audentes Therapeutics |
Director, Gene Therapy Project Management |
Biotechnology |
San Francisco, CA, US |
|
| Damiano Migani |
dmi****@audentestx.com
|
Audentes Therapeutics |
Associate Director CMC Lead |
Biotechnology |
Emeryville, California, United States |
|
| Markus Merilainen |
mme********@audentestx.com
|
Audentes Therapeutics |
Executive Director - Medical Affairs Lead U.S. and Canada |
Biotechnology |
Kailua, HI, US |
|
| Patrick Lynch |
ply***@audentestx.com
|
Audentes Therapeutics |
Director, IT and Automation |
Biotechnology |
Vacaville, CA, US |
|
| Miko Maruoka |
mma*****@audentestx.com
|
Audentes Therapeutics |
Senior Director Regulatory Affairs |
Biotechnology |
San Francisco, CA, US |
|
| Laurence Shah |
lsh**@audentestx.com
|
Audentes Therapeutics |
Senior Director, Medical Affairs, Strategic Planning and Operations |
Biotechnology |
Boston, MA, US |
|
| Kim Perry |
kim******@findex.com.au
|
Findex |
General Counsel |
Financial Services |
Sydney, New South Wales, Australia |
|